PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

NCT04942301 PHASE1 UNKNOWN

This trial is an open-label, randomized, multicenter study to explore Endostar in combination with standard platinum-based chemotherapy with different methods in patients with advanced/metastatic non-small cell lung cancer (NSCLC)

Details

Lead sponsor	Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase	PHASE1
Status	UNKNOWN
Enrolment	24
Start date	Fri Jul 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Oct 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Advanced or Metastatic NSCLC

Interventions

• Endostar
• use the vein pump to pump drugs
• combination therapy

Countries

China